Xenon Pharmaceuticals Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Xenon Pharmaceuticals Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2013 to Q3 2024.
  • Xenon Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 77.9M shares, a 18.1% increase year-over-year.
  • Xenon Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 66.9M shares, a 10.5% increase from 2022.
  • Xenon Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 60.5M shares, a 38.8% increase from 2021.
  • Xenon Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 43.6M shares, a 26.3% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 77.9M +11.9M +18.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 77.7M +11.8M +17.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 77.6M +11.9M +18.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 66.9M +6.35M +10.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 66M +537K +0.82% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 65.9M +9.67M +17.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 65.7M +10.9M +19.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 60.5M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 65.5M +23.2M +54.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 56.2M +14.1M +33.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 54.9M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 42.3M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 42.1M +7.11M +20.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q2 2020 35M +9.21M +35.7% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-06
Q2 2019 25.8M +11.5M +80.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 25.8M +7.95M +44.6% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-07
Q4 2018 19.4M +1.44M +8.01% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-06
Q3 2018 20.3M +2.31M +12.8% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-06
Q2 2018 14.3M -3.69M -20.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 17.8M -142K -0.79% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 18M +2.49M +16.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 18M +2.73M +17.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 18M +3.59M +24.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 17.9M +3.55M +24.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 15.5M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 15.3M +970K +6.79% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 14.4M +166K +1.17% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 14.4M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q3 2015 14.3M +13M +960% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-10
Q2 2015 14.2M +12.9M +957% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q3 2014 1.35M +11.4K +0.85% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 1.35M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q3 2013 1.34M Jul 1, 2013 Sep 30, 2013 10-Q 2014-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.